Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dovel Technologies was a U.S. government-focused technology and consulting company that provided software development, systems integration, cloud, analytics, AI, and digital modernization services. The company had particular domain strength in health IT, life sciences, public safety, grants management, and information management, serving federal agencies including health-related customers such as HHS and NIH. Dovel was founded in 2005 and grew through both organic expansion and acquisitions, including Ace Info Solutions, while also operating subsidiaries such as Medical Science & Computing. In 2021, Guidehouse acquired Dovel and subsequently integrated it into the broader Guidehouse Digital organization, so Dovel no longer operates as an independent standalone company. For biotech analysts, Dovel is best understood not as a drug developer but as a health/life-sciences technology and services contractor supporting biomedical research, clinical research operations, regulatory, and health data environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dovel Technologies.